Ettinger Sarah, Stukenborg-Colsman Christina, Waizy Hazibullah, Becher Christoph, Yao Daiwei, Claassen Leif, Noll Yvonne, Plaass Christian
Orthopedic Surgeon, Department of Orthopedic Surgery, Hannover Medical School, Hannover, Germany.
Orthopedic Surgeon, Department of Orthopedic Surgery, Hannover Medical School, Hannover, Germany.
J Foot Ankle Surg. 2017 Jul-Aug;56(4):788-792. doi: 10.1053/j.jfas.2017.04.001.
Osteochondral defects (OCDs) of the talus remain a surgical challenge, especially after failed primary treatment. The aim of the present study was to examine the clinical outcomes after HemiCAP implantation for OCDs of the medial talar dome after failed previous surgery. Our retrospective study included 11 patients, who had undergone surgery from June 2009 to September 2012 for an OCD of the medial talar dome and received a HemiCAP on the talus after failed previous surgery for OCD. The data were acquired using patients' medical records and standardized questionnaires, including the Foot and Ankle Outcome Score (FAOS), University of California at Los Angeles (UCLA) activity score, EQ-5D, numerical rating scale (NRS), and Short-Form 36-item Health Survey (SF-36). Using these scores, the possibility of returning to work and sports was determined. Any complications and the need for revision surgery were recorded. One patient refused to participate in the study, leaving 10 patients for evaluation. The mean age was 47.64 ± 10.97 years. The mean follow-up period was 43.5 ± 35.51 months. The FAOS and SF-36 subscale scores and the EQ-5D and UCLA activity scores did not improve significantly (p < .05). The mean postoperative pain score on the NRS improved significantly from 6.6 ± 1.77 preoperatively to 5.1 ± 2.02 postoperatively (p < .05). A greater body mass index led to worse postoperative outcomes with higher scores on the pain-NRS and less satisfaction (p < .05). Ten revisions for ongoing pain were performed in 7 patients (70.0%) within a mean of 28.4 ± 13.35 months of the initial procedure, and 6 patients (60%) indicated they would undergo surgery again. The results of the present study have shown that implantation of the HemiCAP as a salvage procedure for OCDs of the talus is challenging and does not consistently lead to good clinical results. Also, overweight patients appear to have an increased risk of postoperative dissatisfaction and persistent ankle pain.
距骨的骨软骨损伤(OCDs)仍然是一个手术难题,尤其是在初次治疗失败后。本研究的目的是探讨在先前手术失败后,采用半帽(HemiCAP)植入治疗距骨内侧穹窿部OCDs的临床疗效。我们的回顾性研究纳入了11例患者,这些患者在2009年6月至2012年9月期间因距骨内侧穹窿部OCDs接受了手术,且在先前OCD手术失败后在距骨上植入了HemiCAP。数据通过患者的病历和标准化问卷收集,包括足踝结局评分(FAOS)、加利福尼亚大学洛杉矶分校(UCLA)活动评分、EQ-5D、数字评定量表(NRS)和简明健康调查36项量表(SF-36)。利用这些评分,确定患者恢复工作和运动的可能性。记录任何并发症以及翻修手术的必要性。1例患者拒绝参与研究,最终有10例患者接受评估。平均年龄为47.64±10.97岁。平均随访期为43.5±35.51个月。FAOS和SF-36子量表评分以及EQ-5D和UCLA活动评分均未显著改善(p<0.05)。NRS上的平均术后疼痛评分从术前的6.6±1.77显著改善至术后的5.1±2.02(p<0.05)。较高的体重指数导致术后结局更差,疼痛-NRS评分更高且满意度更低(p<0.05)。7例患者(70.0%)在初次手术后平均28.4±13.35个月内因持续疼痛进行了10次翻修手术,6例患者(60%)表示他们会再次接受手术。本研究结果表明,将HemiCAP作为距骨OCDs的挽救性手术具有挑战性,且并不能始终带来良好的临床效果。此外,超重患者术后不满和持续性踝关节疼痛的风险似乎更高。